A uPA inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BC-11 (hydrobromide)

Item No. 39522

Technical Information
Formal Name
carbamimidothioic acid, (4-boronophenyl)methyl ester, monohydrobromide
CAS Number
443776-49-6
Synonyms
  • uPA Inhibitor BC-11
  • Urokinase-type Plasminogen Activator Inhibitor BC-11
Molecular Formula
C8H11BN2O2S • HBr
Formula Weight
Purity
≥95%
Formulation
A solid
DMSO: 25 mg/mlEthanol: 20 mg/mlWater: 10 mg/ml
SMILES
NC(SCC1=CC=C(B(O)O)C=C1)=N.Br
InChi Code
InChI=1S/C8H11BN2O2S.BrH/c10-8(11)14-5-6-1-3-7(4-2-6)9(12)13;/h1-4,12-13H,5H2,(H3,10,11);1H
InChi Key
PAFZAMOVHIRQOD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    BC-11 is an inhibitor of the serine protease urokinase-type plasminogen activator (uPA).1 It reduces cell viability of MDA-MB-231 cells (EC50 = 117 µM).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Longo, A., Librizzi, M., Chuckowree, I.S., et alCytotoxicity of the urokinase-plasminogen activator inhibitor carbamimidothioic acid (4-boronophenyl) methyl ester hydrobromide (BC-11) on triple-negative MDA-MB231 breast cancer cells. Molecules 20(6), 9879-9889 (2015).